Summit Trail Advisors’s Hologic HOLX Stock Holding History

Summit Trail Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,550	Closed	-$2.01M	–	1491
2026 Q1	$2.01M	Buy	26,550 +6,780	+34%	+$510K	0.03%	522
2025 Q4	$1.47M	Buy	19,770 +6,658	+51%	+$486K	0.03%	601
2025 Q3	$885K	Buy	13,112 +8,230	+169%	+$546K	0.01%	900
2025 Q2	$318K	Buy	+4,882	New	+$293K	0.01%	901
2018 Q1	–	Sell	-738	Closed	-$32K	–	972
2017 Q4	$32K	Buy	+738	New	+$29.4K	﹤0.01%	924

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Summit Trail Advisors's HOLX Position: Q2 2026 in Review

Summit Trail Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 26,550 shares — an estimated $2.01M sold.

Summit Trail Advisors first reported a position in HOLX in Q4 2017 and held it in 5 quarters. The position peaked at $2.01M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Summit Trail Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Summit Trail Advisors sold 26,550 Hologic shares in Q2 2026, an estimated $2.01M.
Summit Trail Advisors first reported a position in Hologic in Q4 2017 and held it in 5 quarters.
Summit Trail Advisors's Hologic position peaked at $2.01M in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.